相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
A. Kollar et al.
ACTA ONCOLOGICA (2017)
Survival outcomes for cutaneous angiosarcoma of the scalp versus face
Jonathan M. Bernstein et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute
Blase N. Polite et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Simran Sindhu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap et al.
LANCET (2016)
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir et al.
LANCET ONCOLOGY (2016)
Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma
Dai Ogata et al.
MEDICAL ONCOLOGY (2016)
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study
Eddy Pasquier et al.
EBIOMEDICINE (2016)
Refractory Angiosarcoma of the Breast with VEGFR2 Upregulation Successfully Treated with Sunitinib
Edibaldo Silva et al.
BREAST JOURNAL (2015)
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial
Isabelle L. Ray-Coquard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma
Sandra P. D'Angelo et al.
ONCOLOGY (2015)
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade
William Chow et al.
JAMA DERMATOLOGY (2015)
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
Shripad Banavali et al.
ECANCERMEDICALSCIENCE (2015)
Angiosarcoma Outcomes and Prognostic Factors A 25-Year Single Institution Experience
Darya Buehler et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Challenges in the treatment of angiosarcoma: a single institution experience
Smit Singla et al.
AMERICAN JOURNAL OF SURGERY (2014)
First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials
R. J. Young et al.
EUROPEAN JOURNAL OF CANCER (2014)
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
Sam Behjati et al.
NATURE GENETICS (2014)
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas†
M. Agulnik et al.
ANNALS OF ONCOLOGY (2013)
Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
Jessica M. Stiles et al.
PLOS ONE (2013)
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
S. Stacchiotti et al.
ANNALS OF ONCOLOGY (2012)
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N. Penel et al.
ANNALS OF ONCOLOGY (2012)
Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients
K. Ogawa et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
Antoine Italiano et al.
CANCER (2012)
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Petra Hamerlik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)
Isabelle Ray-Coquard et al.
ONCOLOGIST (2012)
Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier et al.
ONCOLOGIST (2012)
Consistent MYC and FLT4 Gene Amplification in Radiation-Induced Angiosarcoma But Not in Other Radiation-Associated Atypical Vascular Lesions
Tianhua Guo et al.
GENES CHROMOSOMES & CANCER (2011)
Angiosarcoma Clinical and Molecular Insights
Guy Lahat et al.
ANNALS OF SURGERY (2010)
Outcome of Locally Recurrent and Metastatic Angiosarcoma
G. Lahat et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
Cristina R. Antonescu et al.
CANCER RESEARCH (2009)
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sporadic cutaneous angiosarcomas: A proposal for risk stratification based on 69 cases
Andrea T. Deyrup et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Cutaneous soft tissue sarcoma incidence patterns in the US - An analysis of 12,114 cases
Panta Rouhani et al.
CANCER (2008)
Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group
M. Schlemmer et al.
EUROPEAN JOURNAL OF CANCER (2008)
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Nicolas Penel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas
Eijun Itakura et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site:: a retrospective study of 161 cases
J. Fayette et al.
ANNALS OF ONCOLOGY (2007)
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Treatment and outcome of 82 patients with angiosarcoma
John A. Abraham et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma
KM Skubitz et al.
CANCER (2005)
A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy
MG Fury et al.
CANCER JOURNAL (2005)
Cutaneous angiosarcoma of the scalp - A multidisciplinary approach
TM Pawlik et al.
CANCER (2003)
分享论文
